ClavystBio

Thank you to all our partners and friends, especially those who travelled long distances, for joining us at ClavystBio Connects 2023. We look forward to furthering the great connections and rich conversations that day! For those who weren't able to join, here's a short video of the day's highlights. Enjoy! #collaboratetoinnovate #clavystbio #clavystbioconnects

[BCS x Gunderson Dettmer Event] Biotech Fundraising: Opportunities & Challenges For all aspiring and existing biotech founders and bioentrepreneurs, BCS and Gunderson Dettmer will be co-organising an in-person workshop on 22 August 2024 (Thursday). The workshop will focus on key fundraising considerations for early-stage startups with a panel discussion on industry trends, challenges and best practices in biotech fundraising. 📅: 22 August 2024, Thursday 🕓: 5:00 pm – 8:00 pm (Registration opens 4.30 pm) 📍: Gunderson Dettmer Singapore    1 Wallich Street, Guoco Tower, #37-03, Singapore 078881 Program outline: 4:30pm-5:00pm: Registration 5:00pm-5:05pm: Introduction 5:05pm-5:30pm: Presentation - Venture Financing Basics 5:30pm-6:45pm: Fireside Chat 7:00pm-8:00pm: Networking (refreshments will be provided) ✍ Click the following link to register: https://lu.ma/tflveh5i

Congrats to our portfolio company NSG BioLabs for a fantastic event last week, deepening partnerships with Amgen and CapitaLand to boost Singapore’s biotech ecosystem! 🚀 This third edition of the NSG BioLabs x Amgen Golden Ticket programme saw double the applicants and has been extended till 2027. PairX Bio won for their innovative research in developing next-generation cancer-selective biologics. 💡Our VP of Therapeutics, Yvonne Koh, joined PairX Bio’s David M Epstein and Amgen's Alan Russell on an insightful panel moderated by Engine Biosciences’s Jeffrey Lu. The focus? The exciting potential of generative biology and AI in unlocking new discoveries. 🏢 NSG BioLabs also announced its expansion to #SingaporeSciencePark's Geneo, making it Southeast Asia’s largest co-working laboratory space. This event showcased the incredible results when people and technology come together! At ClavystBio, we believe that while AI is transformative, talent and collaboration truly drive breakthroughs in life sciences. #clavystcommunity #collaboratetoinnovate #GenerativeBiology #Innovation

Join ClavystBio Medtech Director Yingmin Wang for a discussion on emerging trends in life sciences with Dr. Sharon Chan (Johnson & Johnson) and Stephen Sunderland (L.E.K. Consulting) on 14 Aug (3-6pm). Co-organized by co11ab Novena, Biomedical Science Industry Partnerships Office (#BMSIPO), and SGInnovate, gain insights from industry experts and connect with professionals in the field! Register here: https://lnkd.in/g-JEEzyk

We’re looking forward to hearing from Singapore and global thought leaders on the future and opportunities for clinical trials at the Singapore Clinical Research Institute (SCRI) Clinical Trials Symposium on 30 and 31 July. Join ClavystBio Therapeutics Lead Wen Qi Ho on 31 July (11 am - 12.30pm) as she moderates a panel exploring the path for biotechs conducting clinical trials in Singapore. Panelists include Kon Yew Kwek, BMBCh, DPhil (Hummingbird Bioscience), Choon-Peng (Choon) Ng (ImmunoScape) and Dr Han Chong Toh (National Cancer Centre Singapore and Duke-NUS Medical School). Register here: https://lnkd.in/gRtNTaiU #clinicaltrials #clinicaldevelopment

We’re delighted to welcome Grace C. and Gladys Yeo to the ClavystBio crew! Grace, our new Community Engagement Manager, will be managing ClavystBio’s events to foster impactful connections across the life sciences ecosystem. Gladys, our new Assistant Lab and Office Manager, will be overseeing the operations of labs and offices at #Node1, our dynamic collaboration space at Singapore Science Park. Learn more about our team here: https://lnkd.in/ghWAB_gb #clavystcommunity #collaboratetoinnovate

Last week, we hosted our first Mid-Year Mixer with our ClavystBio Node 1 community. Everyone was encouraged to bring a friend and join in on the fun! It was fantastic to meet, mingle, catch up and have great conversations over hotdogs, beers, and chips. 🍻🌭 A special shoutout to Stephen Hess, #65LAB Expert in Residence, for whipping up an incredible Jalapeno and bacon relish... 🌶️🥓 Stay tuned to our LinkedIn page for more exciting events at our collaboration space, #Node1! #clavystcommunity #collaboratetoinnovate

In this video, ClavystBio Chairman Fidah Alsagoff reflects on his journey building the global life sciences team at Temasek, and the incredible efforts made by Temasek employees during the pandemic. We are grateful to have Fidah’s guidance at ClavystBio on our mission to translate breakthrough ideas into global health impact. #50byFifty #collaboratetoinnovate

ClavystBio CEO Khoo Shih sat down with Citeline Commercial Scrip’s Mandy Jackson to discuss the growing traction in the biotech market. Financing is showing signs of improvement, driven by increased M&A activity from big pharma acquiring smaller firms at attractive valuations. IPOs for clinical-stage companies are also on the rise. Khoo Shih highlighted that while financing prospects are improving, success hinges on companies with a well-articulated story and clear milestones: Key takeaways: • Clarity in Milestones: This is a pivotal time for biotechs to sharpen strategies and communicate their milestones. Investors are looking for companies that can articulate a clear path to value-creating clinical milestones. • Platform Potential: While platforms are valued, the real focus is on the progression of drug candidates. • Strong Insider Commitment: Demonstrating robust internal support is crucial. Read the full article here (for subscribers only): https://lnkd.in/g7DZjZwz

#SLINGSHOT 2024 is back for its 8th edition, and we’re thrilled to share that ClavystBio Medtech Director Yingmin Wang is part of the judging panel identifying promising #lifesciences startups.   As Asia’s leading deep tech competition, SLINGSHOT offers young founders a fantastic platform to showcase their innovations to industry leaders and global investors.   If you have a breakthrough innovation, join the “Health and Biomedical” challenge -- one of five domains in the competition. SLINGSHOT Top 50 Global Startups will win a trip to Singapore to present their innovation at #SWITCHSG, compete for over S$1.2 million in grant prizes, and connect with our vibrant deeptech ecosystem.   Find out more here, and apply by 1 July 2024: https://lnkd.in/gHCAAzvi   #SLINGSHOT2024 #SLINGSHOT #medtech #biotech #innovation